In addition, the production of IL-12 by APCs in the tissues of the anti-PD1 treatment group was higher than that in the control group, and the production of IL-12 in the tumor tissues of the AA and anti-PD1 co-treatment group was significantly higher than that in the anti-PD1 treatment group (Figure 4C). The gene discussed is PDCD1; the disease is neoplasm.